no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Acid-related disorders in the elderly
|
Franceschi, Marilisa |
|
2009 |
38-39 |
6 |
p. 839-848 10 p. |
article |
2 |
Action and function of Akkermansia muciniphila in microbiome ecology, health and disease
|
Ottman, Noora |
|
2017 |
38-39 |
6 |
p. 637-642 |
article |
3 |
Action and function of Chromobacterium violaceum in health and disease: Violacein as a promising metabolite to counteract gastroenterological diseases
|
Justo, Giselle Zenker |
|
2017 |
38-39 |
6 |
p. 649-656 |
article |
4 |
Action and function of Faecalibacterium prausnitzii in health and disease
|
Ferreira-Halder, Carmen Veríssima |
|
2017 |
38-39 |
6 |
p. 643-648 |
article |
5 |
Adaptation following intestinal resection: mechanisms and signals
|
Thiesen Jr., A |
|
2003 |
38-39 |
6 |
p. 981-995 15 p. |
article |
6 |
Advanced endoscopic imaging for gastric cancer assessment: New insights with new optics?
|
Serrano, M. |
|
2014 |
38-39 |
6 |
p. 1079-1091 13 p. |
article |
7 |
Ageing: definitions, mechanisms and the magnitude of the problem
|
Balcombe, Nicholas R |
|
2001 |
38-39 |
6 |
p. 835-849 15 p. |
article |
8 |
Aims & Scope/ Editorial Board
|
|
|
2009 |
38-39 |
6 |
p. iii- 1 p. |
article |
9 |
Aims & Scope/Editorial Board
|
|
|
2016 |
38-39 |
6 |
p. iii- 1 p. |
article |
10 |
Aims & Scope/ Editorial Board
|
|
|
2014 |
38-39 |
6 |
p. iii- 1 p. |
article |
11 |
Aims & scope/editorial board
|
|
|
2006 |
38-39 |
6 |
p. iii- 1 p. |
article |
12 |
Aims ; scope/editorial board
|
|
|
2004 |
38-39 |
6 |
p. iii- 1 p. |
article |
13 |
Aims & scope/Editorial board
|
|
|
2007 |
38-39 |
6 |
p. iii- 1 p. |
article |
14 |
Aims & Scope/ Editorial Board
|
|
|
2010 |
38-39 |
6 |
p. iii- 1 p. |
article |
15 |
Aims & scope/editorial board
|
|
|
2005 |
38-39 |
6 |
p. iii- 1 p. |
article |
16 |
Aims & scope/editorial board
|
|
|
2008 |
38-39 |
6 |
p. iii- 1 p. |
article |
17 |
Aims & Scope/ Editorial Board
|
|
|
2015 |
38-39 |
6 |
p. iii- 1 p. |
article |
18 |
Aims & Scope/ Editorial Board
|
|
|
2011 |
38-39 |
6 |
p. iii- 1 p. |
article |
19 |
Aims & Scope/ Editorial Board
|
|
|
2013 |
38-39 |
6 |
p. iii- 1 p. |
article |
20 |
Aims & Scope/ Editorial Board
|
|
|
2012 |
38-39 |
6 |
p. iii- 1 p. |
article |
21 |
Alterations confined to the gastro-oesophageal junction: the relationship between low LOSP, TLOSRs, hiatus hernia and acid pocket
|
Boeckxstaens, Guy E. |
|
2010 |
38-39 |
6 |
p. 821-829 9 p. |
article |
22 |
Amsterdam and Netherlands gastroenterology: a historical perspective
|
Modlin, Irvin M. |
|
2002 |
38-39 |
6 |
p. 971-998 28 p. |
article |
23 |
An algorithm for diagnosis and treatment of refractory GERD
|
Hershcovici, Tiberiu |
|
2010 |
38-39 |
6 |
p. 923-936 14 p. |
article |
24 |
A pragmatic symptom-based approach
|
Kuo, Paul |
|
2010 |
38-39 |
6 |
p. 765-773 9 p. |
article |
25 |
Assessing and interviewing the elderly: interpretation of signs and symptoms
|
Sklar, Manuel |
|
2001 |
38-39 |
6 |
p. 851-867 17 p. |
article |
26 |
Assessment of a cancer screening program
|
Rabeneck, Linda |
|
2015 |
38-39 |
6 |
p. 979-985 7 p. |
article |
27 |
Atrophy–metaplasia–dysplasia–carcinoma sequence in the stomach: a reality or merely an hypothesis?
|
Meining, A. |
|
2001 |
38-39 |
6 |
p. 983-998 16 p. |
article |
28 |
Autoimmune hepatitis in special patient populations
|
Czaja, Albert J. |
|
2011 |
38-39 |
6 |
p. 689-700 12 p. |
article |
29 |
Autoimmune liver disease
|
Manns, Michael P. |
|
2011 |
38-39 |
6 |
p. 641-642 2 p. |
article |
30 |
Autoimmune liver diseases in children – What is different from adulthood?
|
Mieli-Vergani, Giorgina |
|
2011 |
38-39 |
6 |
p. 783-795 13 p. |
article |
31 |
Biliary tract cancers: From pathogenesis to endoscopic treatment
|
Demols, Anne |
|
2007 |
38-39 |
6 |
p. 1015-1029 15 p. |
article |
32 |
Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs)
|
Kanakis, George |
|
2012 |
38-39 |
6 |
p. 791-802 12 p. |
article |
33 |
Biotherapies for GEP-NETs
|
Öberg, Kjell |
|
2012 |
38-39 |
6 |
p. 833-841 9 p. |
article |
34 |
Cancer surveillance in gastroenterology practice
|
Kaminski, Michal F. |
|
2016 |
38-39 |
6 |
p. 853-854 2 p. |
article |
35 |
Care of the elderly with gastrointestinal problems in family practice
|
Newton, Julia L. |
|
2001 |
38-39 |
6 |
p. 1013-1025 13 p. |
article |
36 |
Changing epidemiology of hepatocellular carcinoma in Asia
|
Goh, George Boon-Bee |
|
2015 |
38-39 |
6 |
p. 919-928 10 p. |
article |
37 |
Chemoprevention trials of GI cancers in Asia
|
Li, James Weiquan |
|
2015 |
38-39 |
6 |
p. 967-978 12 p. |
article |
38 |
Chronic gastritis – An update
|
Varbanova, Mariya |
|
2014 |
38-39 |
6 |
p. 1031-1042 12 p. |
article |
39 |
Chronic viral hepatitis as a public health issue in the world
|
Lavanchy, Daniel |
|
2008 |
38-39 |
6 |
p. 991-1008 18 p. |
article |
40 |
Classification, epidemiology and aetiology
|
Koffeman, Geert I |
|
2003 |
38-39 |
6 |
p. 879-893 15 p. |
article |
41 |
Clinical relevance of Helicobacter pylori vacA and cagA genotypes in gastric carcinoma
|
Ferreira, Rui M. |
|
2014 |
38-39 |
6 |
p. 1003-1015 13 p. |
article |
42 |
Colon cancer and the elderly: From screening to treatment in management of GI disease in the elderly
|
Holt, Peter R. |
|
2009 |
38-39 |
6 |
p. 889-907 19 p. |
article |
43 |
Colonic and rectal NET's
|
Mandair, Dalvinder |
|
2012 |
38-39 |
6 |
p. 775-789 15 p. |
article |
44 |
Colorectal cancer screening
|
Winawer, Sidney J. |
|
2007 |
38-39 |
6 |
p. 1031-1048 18 p. |
article |
45 |
Complications of bile-duct stones: acute cholangitis and pancreatitis
|
van Erpecum, Karel J. |
|
2006 |
38-39 |
6 |
p. 1139-1152 14 p. |
article |
46 |
Constipation in old age
|
Gallagher, Paul |
|
2009 |
38-39 |
6 |
p. 875-887 13 p. |
article |
47 |
Corrigendum to “Current challenges in liver transplantation for hepatocellular carcinoma” [Best Pract Res Clin Gastroenterol 28 (2014) 867–879]
|
Bhoori, Sherrie |
|
2014 |
38-39 |
6 |
p. 1115-1116 2 p. |
article |
48 |
Cost-effectiveness of Barrett's oesophagus screening and surveillance
|
Gordon, Louisa G. |
|
2013 |
38-39 |
6 |
p. 893-903 11 p. |
article |
49 |
Cost-effectiveness of biological agents used in ulcerative colitis
|
Lee, Jeannie K. |
|
2013 |
38-39 |
6 |
p. 949-960 12 p. |
article |
50 |
Cost-effectiveness of liver cancer screening
|
Cucchetti, Alessandro |
|
2013 |
38-39 |
6 |
p. 961-972 12 p. |
article |
51 |
Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
|
Lansdorp-Vogelaar, Iris |
|
2013 |
38-39 |
6 |
p. 933-947 15 p. |
article |
52 |
Cost effectiveness of surveillance for GI cancers
|
Omidvari, Amir-Houshang |
|
2016 |
38-39 |
6 |
p. 879-891 13 p. |
article |
53 |
Cost-effectiveness of viral hepatitis B & C treatment
|
Toy, Mehlika |
|
2013 |
38-39 |
6 |
p. 973-985 13 p. |
article |
54 |
Current trends in the treatment of upper gastrointestinal disease
|
Sachs, George |
|
2002 |
38-39 |
6 |
p. 835-849 15 p. |
article |
55 |
Demography of aging and the epidemiology of gastrointestinal disorders in the elderly
|
Goldacre, Michael J. |
|
2009 |
38-39 |
6 |
p. 793-804 12 p. |
article |
56 |
Diagnosing portal hypertension
|
Wongcharatrawee, Suchat |
|
2000 |
38-39 |
6 |
p. 881-894 14 p. |
article |
57 |
Diagnosis and initial management of Gastroesophageal complications
|
Kamal, Afrin |
|
2010 |
38-39 |
6 |
p. 799-820 22 p. |
article |
58 |
Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes
|
Chevaliez, Stéphane |
|
2008 |
38-39 |
6 |
p. 1031-1048 18 p. |
article |
59 |
Diagnosis and treatment of hepatic encephalopathy
|
Blei, Andres T |
|
2000 |
38-39 |
6 |
p. 959-974 16 p. |
article |
60 |
Diagnosis and treatment of hepatorenal syndrome
|
Ginès, Pere |
|
2000 |
38-39 |
6 |
p. 945-957 13 p. |
article |
61 |
Diagnosis of primary biliary cirrhosis
|
Hirschfield, Gideon M. |
|
2011 |
38-39 |
6 |
p. 701-712 12 p. |
article |
62 |
Diagnosis, treatment and prevention of spontaneous bacterial peritonitis
|
Fernández, Javier |
|
2000 |
38-39 |
6 |
p. 975-990 16 p. |
article |
63 |
Diagnostic criteria for autoimmune hepatitis
|
Lohse, Ansgar W. |
|
2011 |
38-39 |
6 |
p. 665-671 7 p. |
article |
64 |
Diet, microbiome, and colorectal cancer
|
Konstantinov, Sergey R. |
|
2017 |
38-39 |
6 |
p. 675-681 |
article |
65 |
Disease definition, clinical manifestations, epidemiology and natural history of GERD
|
Vakil, Nimish |
|
2010 |
38-39 |
6 |
p. 759-764 6 p. |
article |
66 |
Drug metabolism and drug interactions in the elderly
|
Herrlinger, Charlotte |
|
2001 |
38-39 |
6 |
p. 897-918 22 p. |
article |
67 |
Drug-related damage of the ageing gastrointestinal tract
|
Sostres, Carlos |
|
2009 |
38-39 |
6 |
p. 849-860 12 p. |
article |
68 |
Early diagnosis and treatment of hepatocellular carcinoma
|
Llovet, Josep M |
|
2000 |
38-39 |
6 |
p. 991-1008 18 p. |
article |
69 |
Early esophageal cancer screening in China
|
Gao, Qin-Yan |
|
2015 |
38-39 |
6 |
p. 885-893 9 p. |
article |
70 |
Economic evaluation of colorectal cancer (CRC) screening
|
Cruzado, José |
|
2013 |
38-39 |
6 |
p. 867-880 14 p. |
article |
71 |
Editorial Board
|
|
|
2003 |
38-39 |
6 |
p. iii- 1 p. |
article |
72 |
Effective screening for early diagnosis of pancreatic cancer
|
Hanada, Keiji |
|
2015 |
38-39 |
6 |
p. 929-939 11 p. |
article |
73 |
Endoscopic detection of early lower gastrointestinal cancer
|
Kiesslich, R. |
|
2005 |
38-39 |
6 |
p. 941-961 21 p. |
article |
74 |
Endoscopic detection of early upper GI cancers
|
Wong Kee Song, Louis-Michel |
|
2005 |
38-39 |
6 |
p. 833-856 24 p. |
article |
75 |
Endoscopic mucosal resection for early-stage gastrointestinal cancers
|
Inoue, Haruhiro |
|
2005 |
38-39 |
6 |
p. 871-887 17 p. |
article |
76 |
Endoscopic therapy of early gastric cancer
|
Yamamoto, Hironori |
|
2005 |
38-39 |
6 |
p. 909-926 18 p. |
article |
77 |
Endoscopic therapy of lower gastrointestinal cancer
|
Rembacken, B.J. |
|
2005 |
38-39 |
6 |
p. 979-992 14 p. |
article |
78 |
Endoscopic treatment of high-grade intraepithelial neoplasia and early cancer in Barrett oesophagus
|
Bergman, Jacques J.G.H.M. |
|
2005 |
38-39 |
6 |
p. 889-907 19 p. |
article |
79 |
Endoscopy in gastro-oesophageal reflux disease
|
Hatlebakk, Jan G. |
|
2010 |
38-39 |
6 |
p. 775-786 12 p. |
article |
80 |
Endoscopy in the elderly patient
|
de la Mora, Guillermo |
|
2001 |
38-39 |
6 |
p. 999-1012 14 p. |
article |
81 |
Ensocopic-endoluminal therapies. A critical appraisal
|
Louis, Hubert |
|
2010 |
38-39 |
6 |
p. 969-979 11 p. |
article |
82 |
Enteral and parenteral nutrition in the care of patients with short-bowel syndrome
|
Vanderhoof, Jon A |
|
2003 |
38-39 |
6 |
p. 997-1015 19 p. |
article |
83 |
Environmental – Lifestyle related factors
|
Roman, Sabine |
|
2010 |
38-39 |
6 |
p. 847-859 13 p. |
article |
84 |
Epidemiology of gallbladder stone disease
|
Shaffer, Eldon A. |
|
2006 |
38-39 |
6 |
p. 981-996 16 p. |
article |
85 |
Epidemiology of gastroenteropancreatic neuroendocrine tumours
|
Fraenkel, M. |
|
2012 |
38-39 |
6 |
p. 691-703 13 p. |
article |
86 |
Epidemiology of oesophagogastric cancer
|
Lambert, R. |
|
2007 |
38-39 |
6 |
p. 921-945 25 p. |
article |
87 |
Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic)
|
Tazuma, Susumu |
|
2006 |
38-39 |
6 |
p. 1075-1083 9 p. |
article |
88 |
Erratum
|
|
|
2000 |
38-39 |
6 |
p. 1075- 1 p. |
article |
89 |
Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments
|
Hunt, Richard H. |
|
2002 |
38-39 |
6 |
p. 869-883 15 p. |
article |
90 |
Expected developments in hepatology
|
Forns, Xavier |
|
2002 |
38-39 |
6 |
p. 957-970 14 p. |
article |
91 |
Experimental approaches: dietary and hormone therapy
|
Jeppesen, P.B |
|
2003 |
38-39 |
6 |
p. 1041-1054 14 p. |
article |
92 |
Facts and fantasies in extra-oesophageal symptoms in GORD
|
Labenz, J. |
|
2010 |
38-39 |
6 |
p. 893-904 12 p. |
article |
93 |
Functional disorders of the gastrointestinal tract: Cost effectiveness review
|
Mapel, Douglas W. |
|
2013 |
38-39 |
6 |
p. 913-931 19 p. |
article |
94 |
Future developments in endoscopic imaging
|
Fockens, Paul |
|
2002 |
38-39 |
6 |
p. 999-1012 14 p. |
article |
95 |
Future treatment options for HCV: Double, triple, what is the optimal combination?
|
Kronenberger, Bernd |
|
2008 |
38-39 |
6 |
p. 1123-1136 14 p. |
article |
96 |
Gallstone disease: primary and secondary prevention
|
Venneman, Niels G. |
|
2006 |
38-39 |
6 |
p. 1063-1073 11 p. |
article |
97 |
Gastric acid secretion: Changes during a century
|
Di Mario, Francesco |
|
2014 |
38-39 |
6 |
p. 953-965 13 p. |
article |
98 |
Gastric and duodenal neuroendocrine tumours
|
O'Toole, Dermot |
|
2012 |
38-39 |
6 |
p. 719-735 17 p. |
article |
99 |
Gastric MALT lymphoma – Update on diagnosis and treatment
|
Fischbach, Wolfgang |
|
2014 |
38-39 |
6 |
p. 1069-1077 9 p. |
article |
100 |
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
|
de Herder, Wouter W. |
|
2012 |
38-39 |
6 |
p. 689-690 2 p. |
article |
101 |
Gastrointestinal bleeding in the elderly
|
Lingenfelser, Thomas |
|
2001 |
38-39 |
6 |
p. 963-982 20 p. |
article |
102 |
Gastrointestinal endoscopy in the elderly: Current issues
|
Mönkemüller, Klaus |
|
2009 |
38-39 |
6 |
p. 821-827 7 p. |
article |
103 |
Gastro-oesophageal reflux disease
|
Sifrim, Daniel |
|
2010 |
38-39 |
6 |
p. 757-758 2 p. |
article |
104 |
Generalizability of cost–utility analyses across countries and settings
|
Ginsberg, Gary M. |
|
2013 |
38-39 |
6 |
p. 845-852 8 p. |
article |
105 |
Genetics in primary sclerosing cholangitis
|
Folseraas, Trine |
|
2011 |
38-39 |
6 |
p. 713-726 14 p. |
article |
106 |
Helicobacter pylori: The balance between a role as colonizer and pathogen
|
Otero, Laura Llorca |
|
2014 |
38-39 |
6 |
p. 1017-1029 13 p. |
article |
107 |
Hepatitis B vaccination and prevention of hepatocellular carcinoma
|
Kao, Jia-Horng |
|
2015 |
38-39 |
6 |
p. 907-917 11 p. |
article |
108 |
Hepatobiliary, renal and bone complications of intestinal failure
|
Nightingale, Jeremy Mark Darby |
|
2003 |
38-39 |
6 |
p. 907-929 23 p. |
article |
109 |
Hepatocellular carcinoma in viral hepatitis: Improving standard therapy
|
Masuzaki, Ryota |
|
2008 |
38-39 |
6 |
p. 1137-1151 15 p. |
article |
110 |
Hereditary diffuse gastric cancer – Pathophysiology and clinical management
|
Pinheiro, Hugo |
|
2014 |
38-39 |
6 |
p. 1055-1068 14 p. |
article |
111 |
Immunology of hepatitis B and hepatitis C virus infections
|
Boonstra, Andre |
|
2008 |
38-39 |
6 |
p. 1049-1061 13 p. |
article |
112 |
Implementation of gastric cancer screening – The global experience
|
Leja, Mārcis |
|
2014 |
38-39 |
6 |
p. 1093-1106 14 p. |
article |
113 |
Index
|
|
|
2001 |
38-39 |
6 |
p. I1-I3 nvt p. |
article |
114 |
Index
|
|
|
2000 |
38-39 |
6 |
p. I1-I8 nvt p. |
article |
115 |
Indications for specific therapy in the rehabilitation of patients with the short-bowel syndrome
|
Wilmore, Douglas W |
|
2003 |
38-39 |
6 |
p. 895-906 12 p. |
article |
116 |
Individual risk stratification of gastric cancer: Evolving concepts and their impact on clinical practice
|
Rugge, Massimo |
|
2014 |
38-39 |
6 |
p. 1043-1053 11 p. |
article |
117 |
Intervening in disease through genetically-modified bacteria
|
Ferreira, Adilson K. |
|
2017 |
38-39 |
6 |
p. 693-697 |
article |
118 |
Intervention in gastro-enteropancreatic neuroendocrine tumours
|
Baudin, Eric |
|
2012 |
38-39 |
6 |
p. 855-865 11 p. |
article |
119 |
Intestinal absorption in health and disease: micronutrients
|
Basu, Tapan K |
|
2003 |
38-39 |
6 |
p. 957-979 23 p. |
article |
120 |
Intestinal absorption in health and disease—sugars
|
Wright, Ernest M. |
|
2003 |
38-39 |
6 |
p. 943-956 14 p. |
article |
121 |
Intestinal epithelial pathobiology: past, present and future
|
Gewirtz, Andrew T. |
|
2002 |
38-39 |
6 |
p. 851-867 17 p. |
article |
122 |
Intestinal microbiome and permeability in patients with autoimmune hepatitis
|
Cai, Wangfeng |
|
2017 |
38-39 |
6 |
p. 669-673 |
article |
123 |
Introduction to health economics and decision-making: Is economics relevant for the frontline clinician?
|
Goeree, Ron |
|
2013 |
38-39 |
6 |
p. 831-844 14 p. |
article |
124 |
Is stomach spontaneously ageing? Pathophysiology of the ageing stomach
|
Salles, Nathalie |
|
2009 |
38-39 |
6 |
p. 805-819 15 p. |
article |
125 |
Is there an optimal macronutrient mix for weight loss and weight maintenance?
|
Wilkinson, Dana Lee |
|
2004 |
38-39 |
6 |
p. 1031-1047 17 p. |
article |
126 |
Laboratory based investigations for diagnosing gastroesophageal reflux disease
|
Dolder, Mathias |
|
2010 |
38-39 |
6 |
p. 787-798 12 p. |
article |
127 |
Lifestyle alters GUT-bacteria function: Linking immune response and host
|
Jazayeri, Omid |
|
2017 |
38-39 |
6 |
p. 625-635 |
article |
128 |
Liver disorders in the elderly
|
Floreani, Annarosa |
|
2009 |
38-39 |
6 |
p. 909-917 9 p. |
article |
129 |
Liver transplantation in autoimmune liver diseases
|
Ilyas, Jawad A. |
|
2011 |
38-39 |
6 |
p. 765-782 18 p. |
article |
130 |
Liver transplantation in viral hepatitis: Prevention of recurrence
|
Roche, Bruno |
|
2008 |
38-39 |
6 |
p. 1153-1169 17 p. |
article |
131 |
Liver transplantation of patients in end-stage cirrhosis
|
Haydon, Geoffrey H. |
|
2000 |
38-39 |
6 |
p. 1049-1073 25 p. |
article |
132 |
Management of common bile-duct stones and associated gallbladder stones: surgical aspects
|
Boerma, Djamila |
|
2006 |
38-39 |
6 |
p. 1103-1116 14 p. |
article |
133 |
Management of intrahepatic stones
|
Mori, Toshiyuki |
|
2006 |
38-39 |
6 |
p. 1117-1137 21 p. |
article |
134 |
Medical and endoscopic therapy of primary sclerosing cholangitis
|
Weismüller, Tobias J. |
|
2011 |
38-39 |
6 |
p. 741-752 12 p. |
article |
135 |
Medical treatment of GORD. Emerging therapeutic targets and concepts
|
Zerbib, Frank |
|
2010 |
38-39 |
6 |
p. 937-946 10 p. |
article |
136 |
Medical treatment of portal hypertension
|
Garcı́a-Pagán, Juan Carlos |
|
2000 |
38-39 |
6 |
p. 895-909 15 p. |
article |
137 |
Methodological considerations for surveillance in GI practice
|
Holme, Øyvind |
|
2016 |
38-39 |
6 |
p. 867-878 12 p. |
article |
138 |
Microbiome measurement: Possibilities and pitfalls
|
Radjabzadeh, Djawad |
|
2017 |
38-39 |
6 |
p. 619-623 |
article |
139 |
Microbiome, pattern recognition receptor function in health and inflammation
|
Fawkner-Corbett, David |
|
2017 |
38-39 |
6 |
p. 683-691 |
article |
140 |
Microlithiasis and sludge
|
Jüngst, Christoph |
|
2006 |
38-39 |
6 |
p. 1053-1062 10 p. |
article |
141 |
Minimally invasive surgery for early lower GI cancer
|
Bemelman, W.A. |
|
2005 |
38-39 |
6 |
p. 993-1005 13 p. |
article |
142 |
Modelling the long-term outcomes of bariatric surgery: A review of cost-effectiveness studies
|
Wang, Bruce C.M. |
|
2013 |
38-39 |
6 |
p. 987-995 9 p. |
article |
143 |
Modern, new pharmacotherapy for obesity. A gastrointestinal approach
|
Van Gaal, L. |
|
2004 |
38-39 |
6 |
p. 1049-1072 24 p. |
article |
144 |
Mortality and economics in short bowel syndrome
|
Schalamon, J |
|
2003 |
38-39 |
6 |
p. 931-942 12 p. |
article |
145 |
Multimodal treatment of gastric cancer
|
Moehler, Markus |
|
2007 |
38-39 |
6 |
p. 965-981 17 p. |
article |
146 |
Multimodal treatment of oesophageal cancer
|
Veuillez, Véronique |
|
2007 |
38-39 |
6 |
p. 947-963 17 p. |
article |
147 |
Multimodal treatment of rectal cancer
|
Glynne-Jones, Rob |
|
2007 |
38-39 |
6 |
p. 1049-1070 22 p. |
article |
148 |
NAFLD, Helicobacter species and the intestinal microbiome
|
Castaño-Rodríguez, Natalia |
|
2017 |
38-39 |
6 |
p. 657-668 |
article |
149 |
Natural history: The importance of viral load, liver damage and HCC
|
Wursthorn, Karsten |
|
2008 |
38-39 |
6 |
p. 1063-1079 17 p. |
article |
150 |
Neuroendocrine tumours of the small intestine
|
Strosberg, Jonathan |
|
2012 |
38-39 |
6 |
p. 755-773 19 p. |
article |
151 |
New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity
|
Gupta, Rajnish A |
|
2002 |
38-39 |
6 |
p. 945-956 12 p. |
article |
152 |
Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course
|
Cortez-Pinto, Helena |
|
2004 |
38-39 |
6 |
p. 1089-1104 16 p. |
article |
153 |
Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
|
Bugianesi, Elisabetta |
|
2004 |
38-39 |
6 |
p. 1105-1116 12 p. |
article |
154 |
Non-invasive screening for colorectal cancer in Asia
|
Chiu, Han-Mo |
|
2015 |
38-39 |
6 |
p. 953-965 13 p. |
article |
155 |
Nucleos(t)ide analogues for hepatitis B virus: Strategies for long-term success
|
Chien, Rong-Nan |
|
2008 |
38-39 |
6 |
p. 1081-1092 12 p. |
article |
156 |
Nutrition and oral health
|
Budtz-Jørgensen, Ejvind |
|
2001 |
38-39 |
6 |
p. 885-896 12 p. |
article |
157 |
Nutrition in the elderly
|
Pirlich, Matthias |
|
2001 |
38-39 |
6 |
p. 869-884 16 p. |
article |
158 |
Obesity: epidemiology and clinical aspects
|
Formiguera, Xavier |
|
2004 |
38-39 |
6 |
p. 1125-1146 22 p. |
article |
159 |
Obesity: surgical options
|
Miller, Karl |
|
2004 |
38-39 |
6 |
p. 1147-1165 19 p. |
article |
160 |
Oesophageal disorders: future developments
|
Tam, William |
|
2002 |
38-39 |
6 |
p. 811-833 23 p. |
article |
161 |
Organization of surveillance in GI practice
|
Senore, Carlo |
|
2016 |
38-39 |
6 |
p. 855-866 12 p. |
article |
162 |
Overview of gastrointestinal cancer prevention in Asia
|
Park, Jong-Min |
|
2015 |
38-39 |
6 |
p. 855-867 13 p. |
article |
163 |
Pancreatic cancer: From pathogenesis to cure
|
Ducreux, Michel |
|
2007 |
38-39 |
6 |
p. 997-1014 18 p. |
article |
164 |
Pancreatic neuroendocrine tumors: Clinical features, diagnosis and medical treatment: Advances
|
Ito, Tetsuhide |
|
2012 |
38-39 |
6 |
p. 737-753 17 p. |
article |
165 |
Pathogenesis of autoimmune hepatitis
|
Liberal, Rodrigo |
|
2011 |
38-39 |
6 |
p. 653-664 12 p. |
article |
166 |
Pathogenesis of gallstones: a genetic perspective
|
Grünhage, Frank |
|
2006 |
38-39 |
6 |
p. 997-1015 19 p. |
article |
167 |
Pathogenesis of primary sclerosing cholangitis
|
Pollheimer, Marion J. |
|
2011 |
38-39 |
6 |
p. 727-739 13 p. |
article |
168 |
Pathology – Grading and staging of GEP-NETs
|
Capelli, Paola |
|
2012 |
38-39 |
6 |
p. 705-717 13 p. |
article |
169 |
Pathology of early lower GI cancer
|
Geboes, Karel |
|
2005 |
38-39 |
6 |
p. 963-978 16 p. |
article |
170 |
Pathology of early upper GI cancers
|
Vieth, Michael |
|
2005 |
38-39 |
6 |
p. 857-869 13 p. |
article |
171 |
Pathophysiology, diagnosis and treatment of ascites in cirrhosis
|
Uriz, Juan |
|
2000 |
38-39 |
6 |
p. 927-943 17 p. |
article |
172 |
Peginterferon and ribavirin in HCV: Improvement of sustained viral response
|
Ferenci, P. |
|
2008 |
38-39 |
6 |
p. 1109-1122 14 p. |
article |
173 |
Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues
|
Buster, Erik H.C.J. |
|
2008 |
38-39 |
6 |
p. 1093-1108 16 p. |
article |
174 |
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
|
Bergsma, Hendrik |
|
2012 |
38-39 |
6 |
p. 867-881 15 p. |
article |
175 |
Perception of gastro-oesophageal reflux
|
Chua, Y.C. |
|
2010 |
38-39 |
6 |
p. 883-891 9 p. |
article |
176 |
Perspectives and reflections on integrated digestive surgery
|
Modlin, Irvin M. |
|
2002 |
38-39 |
6 |
p. 885-914 30 p. |
article |
177 |
Pharmacological and alimentary alteration of the gastric barrier
|
Boltin, Doron |
|
2014 |
38-39 |
6 |
p. 981-994 14 p. |
article |
178 |
Physiology and organ-related pathology of the elderly: stomach ulcers
|
Jones, J.I.W. |
|
2001 |
38-39 |
6 |
p. 943-961 19 p. |
article |
179 |
Physiology and pathology of the oesophagus in the elderly patient
|
Lock, Guntram |
|
2001 |
38-39 |
6 |
p. 919-941 23 p. |
article |
180 |
Preface
|
Pilotto, Alberto |
|
2009 |
38-39 |
6 |
p. 791-792 2 p. |
article |
181 |
Preface
|
Tytgat, G.N.J. |
|
2002 |
38-39 |
6 |
p. vii- 1 p. |
article |
182 |
Preface
|
Thomson, A. |
|
2003 |
38-39 |
6 |
p. 877- 1 p. |
article |
183 |
Preface
|
van Erpecum, Karel J. |
|
2006 |
38-39 |
6 |
p. 979-980 2 p. |
article |
184 |
Preface
|
Clandinin, Tom |
|
2004 |
38-39 |
6 |
p. 1007- 1 p. |
article |
185 |
Preface
|
Bergman, J.J.G.H.M. |
|
2005 |
38-39 |
6 |
p. 831-832 2 p. |
article |
186 |
Preface
|
Janssen, Harry |
|
2008 |
38-39 |
6 |
p. 989-990 2 p. |
article |
187 |
Preface
|
Thomson, A.B.R. |
|
2001 |
38-39 |
6 |
p. vii- 1 p. |
article |
188 |
Preface
|
Lau, James Y.W. |
|
2015 |
38-39 |
6 |
p. 841-842 2 p. |
article |
189 |
Preface
|
|
|
2000 |
38-39 |
6 |
p. vii- 1 p. |
article |
190 |
Preface to “Gut microbiome in health and disease”
|
Peppelenbosch, Maikel P. |
|
2017 |
38-39 |
6 |
p. 605-606 |
article |
191 |
Prevention of viral hepatitis (B and C) reassessed
|
Van Herck, Koen |
|
2008 |
38-39 |
6 |
p. 1009-1029 21 p. |
article |
192 |
Prevention strategies for esophageal cancer: Perspectives of the East vs. West
|
Chung, Chen-Shuan |
|
2015 |
38-39 |
6 |
p. 869-883 15 p. |
article |
193 |
Primary sclerosing cholangitis and malignancy
|
Boberg, Kirsten Muri |
|
2011 |
38-39 |
6 |
p. 753-764 12 p. |
article |
194 |
Psychological aspects of eating disorders
|
Williamson, Donald A. |
|
2004 |
38-39 |
6 |
p. 1073-1088 16 p. |
article |
195 |
Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours
|
Sundin, Anders |
|
2012 |
38-39 |
6 |
p. 803-818 16 p. |
article |
196 |
Review: Surveillance of patients with Barrett oesophagus
|
Maes, Sielte |
|
2016 |
38-39 |
6 |
p. 901-912 12 p. |
article |
197 |
Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment
|
Freeman, Hugh J. |
|
2004 |
38-39 |
6 |
p. 1167-1175 9 p. |
article |
198 |
Screening of gastric cancer in Asia
|
Sugano, Kentaro |
|
2015 |
38-39 |
6 |
p. 895-905 11 p. |
article |
199 |
Second look endoscopy in acute non-variceal upper gastrointestinal bleeding
|
Chiu, Philip Wai Yan |
|
2013 |
38-39 |
6 |
p. 905-911 7 p. |
article |
200 |
Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours
|
Costa, F.P. |
|
2012 |
38-39 |
6 |
p. 843-854 12 p. |
article |
201 |
Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs?
|
Bruley des Varannes, Stanislas |
|
2010 |
38-39 |
6 |
p. 905-921 17 p. |
article |
202 |
Small intestinal disorders in the elderly
|
Thomson, Alan B.R. |
|
2009 |
38-39 |
6 |
p. 861-874 14 p. |
article |
203 |
Splenomegaly, hypersplenism and coagulation abnormalities in liver disease
|
McCormick, P.Aiden |
|
2000 |
38-39 |
6 |
p. 1009-1031 23 p. |
article |
204 |
Surgery for GEP-NETs
|
Knigge, Ulrich |
|
2012 |
38-39 |
6 |
p. 819-831 13 p. |
article |
205 |
Surgical approaches and intestinal transplantation
|
Benedetti, Enrico |
|
2003 |
38-39 |
6 |
p. 1017-1040 24 p. |
article |
206 |
Surgical aspects in management of hepato-pancreatico-biliary tumours in the elderly
|
di Sebastiano, Pierluigi |
|
2009 |
38-39 |
6 |
p. 919-923 5 p. |
article |
207 |
Surgical aspects of symptomatic cholecystolithiasis and acute cholecystitis
|
Keus, F. |
|
2006 |
38-39 |
6 |
p. 1031-1051 21 p. |
article |
208 |
Surgical strategies for early esophageal adenocarcinoma
|
Stein, H.J. |
|
2005 |
38-39 |
6 |
p. 927-940 14 p. |
article |
209 |
Surgical therapy of gastro-oesophageal reflux disease
|
Lundell, Lars |
|
2010 |
38-39 |
6 |
p. 947-959 13 p. |
article |
210 |
Surgical treatment of portal hypertension
|
Henderson, J.Michael |
|
2000 |
38-39 |
6 |
p. 911-925 15 p. |
article |
211 |
Surveillance after colorectal polyp removal
|
Jover, Rodrigo |
|
2016 |
38-39 |
6 |
p. 937-948 12 p. |
article |
212 |
Surveillance after endoscopic and surgical resection of colorectal cancer
|
Sekiguchi, Masau |
|
2016 |
38-39 |
6 |
p. 959-970 12 p. |
article |
213 |
Surveillance for hepatocellular carcinoma
|
Díaz-González, Álvaro |
|
2016 |
38-39 |
6 |
p. 1001-1010 10 p. |
article |
214 |
Surveillance for neoplasia in the pancreas
|
Overbeek, Kasper A. |
|
2016 |
38-39 |
6 |
p. 971-986 16 p. |
article |
215 |
Surveillance in cholangiocellular carcinoma
|
Wirth, Thomas C. |
|
2016 |
38-39 |
6 |
p. 987-999 13 p. |
article |
216 |
Surveillance of patients at high-risk of squamous cell esophageal cancer
|
Chaber-Ciopinska, A. |
|
2016 |
38-39 |
6 |
p. 893-900 8 p. |
article |
217 |
Surveillance of patients with gastric precancerous conditions
|
Lage, Jorge |
|
2016 |
38-39 |
6 |
p. 913-922 10 p. |
article |
218 |
Surveillance of patients with hereditary gastrointestinal cancer syndromes
|
Moreira, Leticia |
|
2016 |
38-39 |
6 |
p. 923-935 13 p. |
article |
219 |
Surveillance of patients with inflammatory bowel disease
|
Yu, Jessica X. |
|
2016 |
38-39 |
6 |
p. 949-958 10 p. |
article |
220 |
Symptoms and diagnosis of gallbladder stones
|
Portincasa, P. |
|
2006 |
38-39 |
6 |
p. 1017-1029 13 p. |
article |
221 |
Symptoms, diagnosis and endoscopic management of common bile duct stones
|
Caddy, Grant R. |
|
2006 |
38-39 |
6 |
p. 1085-1101 17 p. |
article |
222 |
Taming the mucosal immune response in Crohn's disease
|
van Deventer, S.J.H. |
|
2002 |
38-39 |
6 |
p. 1035-1043 9 p. |
article |
223 |
Targeted screening for colorectal cancer in high-risk individuals
|
Wong, Martin C.S. |
|
2015 |
38-39 |
6 |
p. 941-951 11 p. |
article |
224 |
The benefit of animal models for autoimmune hepatitis
|
Jaeckel, Elmar |
|
2011 |
38-39 |
6 |
p. 643-651 9 p. |
article |
225 |
The changing epidemiology of Asian digestive cancers: From etiologies and incidences to preventive strategies
|
Wu, Chun-Ying |
|
2015 |
38-39 |
6 |
p. 843-853 11 p. |
article |
226 |
The Comprehensive Geriatric Assessment and the multidimensional approach. A new look at the older patient with gastroenterological disorders
|
Pilotto, Alberto |
|
2009 |
38-39 |
6 |
p. 829-837 9 p. |
article |
227 |
The current future understanding of inflammatory bowel disease
|
Podolsky, Daniel K. |
|
2002 |
38-39 |
6 |
p. 933-943 11 p. |
article |
228 |
The diagnostic and therapeutic approach for primary solid liver tumours in adults
|
Verslype, Chris |
|
2007 |
38-39 |
6 |
p. 983-996 14 p. |
article |
229 |
The fight against gastric cancer – the IARC Working Group report
|
Herrero, Rolando |
|
2014 |
38-39 |
6 |
p. 1107-1114 8 p. |
article |
230 |
The gastrointestinal microbiome – Functional interference between stomach and intestine
|
Lopetuso, Loris R. |
|
2014 |
38-39 |
6 |
p. 995-1002 8 p. |
article |
231 |
The gastrointestinal microbiota and its role in oncogenesis
|
Lam, S.Y. |
|
2017 |
38-39 |
6 |
p. 607-618 |
article |
232 |
The global challenge of a healthy stomach
|
Bornschein, Jan |
|
2014 |
38-39 |
6 |
p. 949-951 3 p. |
article |
233 |
The hepatopulmonary syndrome
|
Aboussouan, Loutfi S |
|
2000 |
38-39 |
6 |
p. 1033-1048 16 p. |
article |
234 |
The host–microbe interface within the gut
|
Shanahan, Fergus |
|
2002 |
38-39 |
6 |
p. 915-931 17 p. |
article |
235 |
The increasing need for health-economic assessment in gastrointestinal and liver diseases
|
Bardou, Marc |
|
2013 |
38-39 |
6 |
p. 829-830 2 p. |
article |
236 |
The integration of cytotoxics and biologicals in the treatment of metastatic colorectal cancer
|
Van Cutsem, Eric |
|
2007 |
38-39 |
6 |
p. 1089-1108 20 p. |
article |
237 |
The integrity of the esophageal mucosa. Balance between offensive and defensive mechanisms
|
Orlando, Roy C. |
|
2010 |
38-39 |
6 |
p. 873-882 10 p. |
article |
238 |
The multidisciplinary management of gastrointestinal cancer
|
Van Cutsem, Eric |
|
2007 |
38-39 |
6 |
p. 919-920 2 p. |
article |
239 |
Therapy of autoimmune hepatitis
|
Strassburg, Christian P. |
|
2011 |
38-39 |
6 |
p. 673-687 15 p. |
article |
240 |
The refluxate: The impact of its magnitude, composition and distribution
|
Woodland, Philip |
|
2010 |
38-39 |
6 |
p. 861-871 11 p. |
article |
241 |
The relation between body mass and gastro-oesophageal reflux
|
Nilsson, Magnus |
|
2004 |
38-39 |
6 |
p. 1117-1123 7 p. |
article |
242 |
The role of delayed gastric emptying and impaired oesophageal body motility
|
Penagini, Roberto |
|
2010 |
38-39 |
6 |
p. 831-845 15 p. |
article |
243 |
The role of exercise for weight loss and maintenance
|
Donnelly, Joseph E. |
|
2004 |
38-39 |
6 |
p. 1009-1029 21 p. |
article |
244 |
The stomach–brain axis
|
Holtmann, Gerald |
|
2014 |
38-39 |
6 |
p. 967-979 13 p. |
article |
245 |
The use of molecular markers in the diagnosis and treatment of colorectal cancer
|
Tejpar, Sabine |
|
2007 |
38-39 |
6 |
p. 1071-1087 17 p. |
article |
246 |
Treatment of GERD complications (Barrett’s, peptic stricture) and extra-oesophageal syndromes
|
Bansal, Ajay |
|
2010 |
38-39 |
6 |
p. 961-968 8 p. |
article |
247 |
Treatment of pancreatic cancer: A narrative review of cost-effectiveness studies
|
Bardou, Marc |
|
2013 |
38-39 |
6 |
p. 881-892 12 p. |
article |
248 |
Understanding and controlling hepatobiliary function
|
Oude Elferink, Ronald P.J. |
|
2002 |
38-39 |
6 |
p. 1025-1034 10 p. |
article |
249 |
Understanding and controlling the enteric nervous system
|
Boeckxstaens, G.E. |
|
2002 |
38-39 |
6 |
p. 1013-1023 11 p. |
article |
250 |
What is the impact of disease prevalence upon health technology assessment?
|
Rotily, Michel |
|
2013 |
38-39 |
6 |
p. 853-865 13 p. |
article |